| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 07/10/2008 | US20080166400 Pharmaceutically acceptable phosphate-glycerol carrying bodies |
| 07/10/2008 | US20080166399 Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| 07/10/2008 | US20080166398 Antifungal Compositions |
| 07/10/2008 | US20080166396 Thrombin domains; for preventing flight deep vein thrombosis or thrombosis in intermittent apheresis |
| 07/10/2008 | US20080166395 Pouches for nicotine replacement therapy; coconuts, flavors, herbs |
| 07/10/2008 | US20080166393 For contact lenses; sealed pouches |
| 07/10/2008 | US20080166391 Zero-order prolonged release coaxial implants |
| 07/10/2008 | US20080166389 Compositions and methods for treatment of hyperplasia |
| 07/10/2008 | US20080166387 Anti-angiogenic compositions and methods of use |
| 07/10/2008 | US20080166386 Glycolic acid-lactic acid copolymers as bulking agent; soft tissue augmentation |
| 07/10/2008 | US20080166385 Such as sponges; gelling hydrocolloid polymeric cellulose acetate phthalate in aqueous solvent, exposing to radiant energy under vacuum to boil solvent |
| 07/10/2008 | US20080166383 PVC (polyvinyl chloride); solves the problem of hypersensitivity to condom or glove; contains matrine and/or sodium ferulate |
| 07/10/2008 | US20080166382 Amphiphilic block copolymers and nanoparticles comprising the same |
| 07/10/2008 | US20080166381 Emulsifier Composition Based on Pentaerythritol Esters and Aloxylated Nonionic Emulsifiers |
| 07/10/2008 | US20080166380 Drug encapsulated polymer micelles formed from a block copolymer having a hydrophilic segment and hydrophobic segment, and has been subjected to high-pressure treatment; drug delivery |
| 07/10/2008 | US20080166346 Freeze dried monoclonal antibody specific for endothelial growth factor receptors for use treatment of cell proliferative disorders; enhanced storage stability |
| 07/10/2008 | US20080166306 Administering a grape cell line culture; anti-inflammatory |
| 07/10/2008 | US20080166305 Aerosols with tetrafluoropropenes as blowing agents; inhalers; lubricants |
| 07/10/2008 | US20080166304 Contacting the microorganism with a phenothiazinium and a microbial MDR inhibitor and irradiating the phenothiazinium producing a phototoxic species that inactivates the microorganism |
| 07/10/2008 | US20080166303 Colored or colorable foamable composition and foam |
| 07/10/2008 | DE10250727B4 Matrix mit einer bioaktiven Phospholipid-haltigen Komponente Matrix with a bioactive phospholipid-containing component |
| 07/10/2008 | DE102007001473A1 Manufacture of micro- and nano suspensions used in pharmaceutical, chemical, food, textile and agrarian industries, employs solid carbon dioxide and high pressure homogenizer |
| 07/10/2008 | CA2674226A1 Compositions and methods of their use for improving the condition and appearance of skin |
| 07/10/2008 | CA2674063A1 Compounds, compositions, kits and methods of use to orally and topically treat acne and other skin conditions by administering a 19-nor containing vitamin d analog with or withouta retinoid |
| 07/10/2008 | CA2673976A1 Gel composition for treating mycosis |
| 07/10/2008 | CA2673924A1 Liposomal pharmaceutical preparation and method for manufacturing the same |
| 07/10/2008 | CA2673232A1 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature |
| 07/10/2008 | CA2672964A1 Pharmaceutical compositions and method for treating inflammation in cattle and other animals |
| 07/10/2008 | CA2672888A1 Methods and formulations for improved bioavailability of antiprogestins |
| 07/10/2008 | CA2672538A1 Pharmaceutical compositions of alkyl gallates |
| 07/10/2008 | CA2671925A1 Sustained-release formulations comprising crystals, macromolecular gels, and particulate suspensions of biologic agents |
| 07/09/2008 | EP1941901A1 An exterior-applied formulation and its preparation methods and uses |
| 07/09/2008 | EP1941896A1 Dipeptide-containing composition for oral administration |
| 07/09/2008 | EP1941880A1 Lotion preparation containing pyridonecarboxylic acid derivative |
| 07/09/2008 | EP1941878A1 Sedative non-benzodiazepine formulations |
| 07/09/2008 | EP1941871A1 Formulations for prevention and treatment of breast cancer with 4-hydroxy tamoxifen |
| 07/09/2008 | EP1941869A1 Multicompartment bag for storage of iron preparations |
| 07/09/2008 | EP1941868A2 Improvements in or relating to the delivery of oral drugs |
| 07/09/2008 | EP1941867A1 Prevention and reduction of blood loss |
| 07/09/2008 | EP1941862A1 Tablet for removal of tongue coating |
| 07/09/2008 | EP1941062A1 Method for producing a saccharose composition, resulting product and use thereof |
| 07/09/2008 | EP1940983A1 Coating agent |
| 07/09/2008 | EP1940775A2 Methods and compositions for the efficient delivery of therapeutic agents to cells and animals |
| 07/09/2008 | EP1940478A2 Wound-healing pharmaceutical compositions in the form of a sterile powder based on amino acids and sodium hyaluronate |
| 07/09/2008 | EP1940467A2 Sustained drug release composition |
| 07/09/2008 | EP1940459A2 Solid solution perforator containing drug particle and/or drug-adsorbed particles |
| 07/09/2008 | EP1940439A1 Reducing post-operative adhesion formation with intraperitoneal glutamine |
| 07/09/2008 | EP1940428A1 Bile preparations for gastrointestinal disorders |
| 07/09/2008 | EP1940427A2 Encapsulation system |
| 07/09/2008 | EP1940414A2 Anti mineralocorticoid therapy of infection |
| 07/09/2008 | EP1940396A1 Anthelmintic formulations |
| 07/09/2008 | EP1940391A1 Stabilized extended release pharmeceutical compositions comprising an hmg-coa reductase inhibitor |
| 07/09/2008 | EP1940383A1 Treatment and prevention of benign pigmented moles (naevi) using artemisinine and the derivatives thereof |
| 07/09/2008 | EP1940368A2 Transdermal drug delivery system with acrylate or methacrylate functional pressure sensitive adhesive composition |
| 07/09/2008 | EP1940367A2 Antiviral lip plaster |
| 07/09/2008 | EP1940366A1 Soft capsules comprising palonosetron hydrochloride having improved stability and bioavailability |
| 07/09/2008 | EP1940365A2 Liquid dosage forms having enteric properties of delayed and then sustained release |
| 07/09/2008 | EP1940364A2 Capsule formulation of pirfenidone and pharmaceutically acceptable excipients |
| 07/09/2008 | EP1940363A2 Chocolate coated spherical filled capsules |
| 07/09/2008 | EP1940362A2 Oral composition containing a salivation inducing agent |
| 07/09/2008 | EP1940361A2 Pharmaceutical dosage forms having immediate release and/or controlled release properties |
| 07/09/2008 | EP1940360A1 Dispersible tablets comprising deferasirox |
| 07/09/2008 | EP1940359A1 Method for the production of directly compressible ibuprofen formulations |
| 07/09/2008 | EP1940358A2 Pharmaceutical compositions |
| 07/09/2008 | EP1940357A2 Pharmaceutical compositions |
| 07/09/2008 | EP1940356A1 Encapsulation and controlled release of biologically active ingredients with enzymatically degradable microparticulate hyper-branched polymers |
| 07/09/2008 | EP1940355A2 Drug delivery nanocarriers targeted by landscape phage |
| 07/09/2008 | EP1940354A2 Injectable viscous medicinal preparation comprising ethanol and an x-ray opaque fat-soluble compound |
| 07/09/2008 | EP1940353A2 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 07/09/2008 | EP1940352A1 Method of preparing an aqueous pharmaceutical composition comprising hydroxypropyl methylcellulose and pharmaceutical c0mp0siti0ns obtainable |
| 07/09/2008 | EP1940351A2 Sustained release small molecule drug formulation |
| 07/09/2008 | EP1940350A1 A delivery system |
| 07/09/2008 | EP1940349A2 Aerosol formulation for the inhalation of beta agonists |
| 07/09/2008 | EP1940339A1 Dental implant and production method for said implant |
| 07/09/2008 | EP1940300A2 Method for treating subcutaneous tissues |
| 07/09/2008 | EP1940241A2 Stable, durable granules with active agents |
| 07/09/2008 | EP1784164A4 Methods for transmembrane treatment and prevention of otitis media |
| 07/09/2008 | EP1755650B1 A biomolecule-containing suspension formulation of increased stability deliverable via an implantable delivery device |
| 07/09/2008 | EP1727553B1 Agent for substitution of blood plasma and a method of its production |
| 07/09/2008 | EP1694320B1 Use of compositions comprising oleanic acid and ursolic acid for the preparation of a medicament for the treatment of hypersensitivity and hyperreactivity |
| 07/09/2008 | EP1684730B1 Pharmaceutical composition having a cationic excipient |
| 07/09/2008 | EP1603615B1 Improved dry powder inhaler system |
| 07/09/2008 | EP1572167B1 Transdermal buprenorphine dosage regimen for analgesia |
| 07/09/2008 | EP1534070A4 Methods for treating fungal infections |
| 07/09/2008 | EP1530464B1 Aerosol formulation for inhalation containing an anticholinergic agent |
| 07/09/2008 | EP1492577B1 Film-forming compositions for protecting skin from body fluids and articles made therefrom |
| 07/09/2008 | EP1469858B1 Non-nucleosidic inhibitors of reverse transcriptase as antagonists of cell proliferation and inducers of cell differentiation |
| 07/09/2008 | EP1455762A4 Solid formulation producing carbon dioxide when contacting liquid acid and a method of preparing the same |
| 07/09/2008 | EP1455756B1 Pharmaceutical nanoparticulate composition of a tachykinin receptor antagonist |
| 07/09/2008 | EP1427391B1 Solid-phase agent for vascular occlusion with immobilised platelet binding agent |
| 07/09/2008 | EP1411780B1 Soluble roasted chicory with high inulin content |
| 07/09/2008 | EP1372758B1 Method for eliminating potentially toxic and/or harmful substances |
| 07/09/2008 | EP1372383B1 A product comprising a susbtrate and an antimicrobial formulation |
| 07/09/2008 | EP1370243B1 Method to obtain microparticles containing a h+, k+ -atp-ase inhibitor |
| 07/09/2008 | EP1296917B1 Method for obtaining a purified hydrofluoroalkane |
| 07/09/2008 | EP1233784B1 Compositions and methods for stabilizing biological molecules upon lyophilization |
| 07/09/2008 | EP1061900B2 Dermal compositions |
| 07/09/2008 | EP1043023B1 Viscous compositions containing carbon dioxide |
| 07/09/2008 | EP1011721B1 Vaginal lactobacillus medicant |
| 07/09/2008 | EP0968712B1 Felbinac-containing patch |